stars 1 stars 2 stars 3

The European Federation for Exploratory Medicines Development – EUFEMED – was founded in 2015 as a result of an ongoing, informal collaboration between several European societies active in the area of human pharmacology. EUFEMED has been recognized as a stakeholder by EMA and is consulted for the revision of important European regulations and guidelines related to clinical drug development. EUFEMED is a not for profit association established under the Belgian law. In order to strengthen the voice of EUFEMED and in the importance of early medicines development in Europe, other societies and additional countries are invited to become members.

EUFEMED Questions

The EUFEMED annual revenue was $144.8 million in 2026.

Rob Zuiker is the President Elect of EUFEMED.

1 people are employed at EUFEMED.

The NAICS codes for EUFEMED are [3254, 325, 32541, 32].

The SIC codes for EUFEMED are [283, 28].

Top EUFEMED Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users